10-Q quarterly report · filed Nov 5, 2026

Guardian Pharmacy Services, Inc. (GRDN) Q3 2026 10-Q Quarterly Report

Short answer

Guardian Pharmacy Services, Inc. (GRDN) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $371M (down 1.7% year over year) with net income of $19M.

Q3 2026 key financials · XBRL

Revenue
$371M
−1.7% YoY · +5.5% QoQ
Net income
$19M
+90.3% YoY · −14.6% QoQ
Operating margin
6.8%
Gross margin
23.0%
EPS (diluted)
$0.84

Source: XBRL data from the Guardian Pharmacy Services, Inc. (GRDN) Q3 2026 10-Q on SEC EDGAR. USD.

Guardian Pharmacy Services, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $371.1M, down 1.7% from $377.4M, reflecting IRA-related pricing reductions
  • Gross margin 23.0% vs 19.8%; net margin 5.2% vs 2.5% YoY
  • Acquisitions strongest contributor, adding $7.3M revenue; organic revenue decreased $13.7M
  • Cash $119.7M; nine-month operating cash flow $79.5M vs $65.7M, up $13.8M
  • IRA price reductions remain a headwind, expected to affect year-over-year comparability through the remainder of 2026

Risk Factors

  • No material changes to risk factors since the December 31, 2025 Form 10-K
  • Regulatory risk: existing 10-K risks remain applicable to pharmacy operations
  • Operational risk: carried-forward 10-K risks could adversely affect business and results
  • Financial risk: existing 10-K risks could adversely affect financial condition and prospects
  • Market risk: carried-forward risks could reduce Class A common stock price

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Guardian Pharmacy Services, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.